| Date Filed | Type | Description |
| 03/01/2023 |
4
| Jacques Rachelle Suzanne (Director) has filed a Form 4 on uniQure N.V.|
Txns:
| Sold 384 shares
@ $20.02, valued at
$7.7k
|
|
| 06/17/2022 |
4
| Jacques Rachelle Suzanne (Director) has filed a Form 4 on uniQure N.V.|
Txns:
| Granted 9,080 shares
@ $0
Granted 17,810 options to buy
@ $14.08, valued at
$250.8k
|
|
| 05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/22/2021 |
4
| Jacques Rachelle Suzanne (Director) has filed a Form 4 on uniQure N.V.|
Txns:
| Granted 10,000 options to buy
@ $28.24, valued at
$282.4k
|
|
| 10/22/2021 |
3
| Jacques Rachelle Suzanne (Director) has filed a Form 3 on uniQure N.V. |
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2020 |
4/A
| Jacques Rachelle Suzanne (Director) has filed a Form 4 on Viela Bio, Inc.|
Txns:
| Granted 14,716 options to buy
@ $48.96, valued at
$720.5k
Granted 7,358 options to buy
@ $48.96, valued at
$360.2k
|
|
| 06/23/2020 |
4
| Jacques Rachelle Suzanne (Director) has filed a Form 4 on Viela Bio, Inc.|
Txns:
| Granted 14,716 options to buy
@ $48.96, valued at
$720.5k
|
|
| 05/22/2020 |
4
| Jacques Rachelle Suzanne (Director) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.|
Txns:
| Granted 40,500 options to buy
@ $7.3, valued at
$295.7k
|
|
| 05/04/2020 |
3
| Jacques Rachelle Suzanne (Director) has filed a Form 3 on Viela Bio, Inc. |
| 06/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/08/2019 |
4
| Jacques Rachelle Suzanne (Director) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.|
Txns:
| Granted 68,000 options to buy
@ $7.8, valued at
$530.4k
|
|
| 04/08/2019 |
3
| Jacques Rachelle Suzanne (Director) has filed a Form 3 on Corbus Pharmaceuticals Holdings, Inc. |